Vanguard Capital Management’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.6M Buy
7,888,020
+6,165,203
+358% +$12M ﹤0.01% 2719
2026
Q2
$3.6M Buy
1,722,817
+293,509
+21% +$578K ﹤0.01% 3229
2026
Q1
$2.5M Buy
+1,429,308
New +$2.6M ﹤0.01% 3289

Other funds holding PALI

Vanguard Capital Management's PALI Position: Q3 2026 in Review

Vanguard Capital Management increased its Palisade Bio (PALI) stake by 358% in Q3 2026, buying an estimated $12M and bringing the position to 7,888,020 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2719.

Vanguard Capital Management first reported a position in PALI in Q1 2026 and has held it in 3 quarters since. 114 funds tracked by Wall St. Rank hold PALI as of Q3 2026.

  • Vanguard Capital Management held 7,888,020 shares of Palisade Bio worth $10.6M as of Q3 2026.
  • Vanguard Capital Management bought 6,165,203 Palisade Bio shares in Q3 2026, an estimated $12M.
  • Palisade Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2719 holding.
  • Vanguard Capital Management first reported a position in Palisade Bio in Q1 2026 and has held it in 3 quarters since.
  • 114 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.